PFIZER INC → Haleon plc HLNCF

Stake: 7.30% Shares: 661,709,764 CUSIP: 405552100 Class: Ordinary Shares, nominal value GBP0.01 per share

Item 4 — Purpose of Transaction

Item 4 of the Schedule 13D is hereby supplemented as follows: As previously disclosed, the Pfizer Relationship Agreement terminated following the closing of the January 2025 Secondary Offering and Pfizer no longer has the contractual right to nominate representative directors to be appointed to the Board. As a result, Mr. Supran stepped down from the Board on February 25, 2025.

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

3 13D/G filings on this issuer

2 other filings besides this one

Filer Track Record

3 filings by this filer

2 other filings in the data moat

Short Interest · settle 2026-03-31

DTC 123.67

4,307,008 shares short · +7.3% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $47.92M

Point72 Asset Mgmt

Other 13D/G Filings on Haleon plc

Filed	Form	Filer	Stake	Shares
2025-01-21	SCHEDULE	PFIZER INC	7.30%	661,709,764	view →
2025-01-16	SCHEDULE	PFIZER INC	15.00%	1,361,709,764	view →

Other Filings by PFIZER INC

Filed	Form	Issuer	Stake	Shares
2025-01-21	SCHEDULE	Haleon plc HLNCF	7.30%	661,709,764	view →
2025-01-16	SCHEDULE	Haleon plc HLNCF	15.00%	1,361,709,764	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →